Anti-helicobacter pylori effect of total alkaloids of sophora alopecuroides in vivo
Background Helicobacterpylori (H.pylori) infection could lead to most gastroduodenal diseases and is even identified as a carcinogen of gastric cancer.Total alkaloids of sophora alopecuroides (TASA) is widely used in herbal remedies to treat various infectious diseases,including stomach-associated d...
Gespeichert in:
Veröffentlicht in: | Chinese medical journal 2014, Vol.127 (13), p.2484-2491 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2491 |
---|---|
container_issue | 13 |
container_start_page | 2484 |
container_title | Chinese medical journal |
container_volume | 127 |
creator | Tian, Aiping Xu, Ting Liu, Kaiyun Zou, Quanming Yan, Xiang |
description | Background Helicobacterpylori (H.pylori) infection could lead to most gastroduodenal diseases and is even identified as a carcinogen of gastric cancer.Total alkaloids of sophora alopecuroides (TASA) is widely used in herbal remedies to treat various infectious diseases,including stomach-associated diseases.This study is aimed at evaluating the antimicrobial activity of TASA on H.pylori-infected BALB/c mice mouse gastritis.Methods Totally 120 BALB/c mice were orally inoculated with H.pylori Bacterial liquid to construct BALB/c mice H.pylori infection gastritis animal model,after the model was successfully created.We randomly assigned 100 infected mice into 10 treatment groups,the first group (normal saline); the second group (bismuth pectin); the third group (omeprazole); the fourth group (TASA 2 mg/d); the fifth group (TASA 4 mg/d); the sixth group (TASA 5 mg/d); the seventh group (TASA + bismuth pectin); the eighth group (TASA + omeprazole); the ninth group (bismuth pectin + clarithromycin + metronidazole);the tenth group (omeprazole + clarithromycin + metronidazole),5 other non-infected mice as negative control.Mice were orally inoculated twice a day and 7 days continuously.Then the mice were killed 4 weeks after treatment,we used realtime PCR to detect 16sDNA of H.pylori to test both the colonization and the clearance mice of bacteria of each treatment.We applied hematoxylin and eosin (HE) staining and immunostaining of mice gastric mucosa to observe the general inflammation and related factors interleukin 8 (IL-8),cyclooxygenase 2 (COX-2),and nuclear factor-kappa B (NF-KB) expression change after treatments.Results Firstly,we ensured that after 6-week intragastric administration,the bacteria colonization reached an exceed peak which is far higher than positive threshold (P <0.001); secondly,after treatments,it is revealed that TASA combined with omeprazole or bismuth pectin showed promising antimicrobial activity against H.pylori as well as conventional triple therapy (P <0.001); thirdly,HE staining showed that the inflammation on mice gastric mucosal membrane were also relieved obviously in TASA combined treatments and conventional triple therapy compared with normal saline treated mice,moreover,from immunohistochemistry results,H.pylori-induced IL-8,COX-2,and NF-KB were consistently suppressed in seventh,eighth,ninth,and tenth group to a certain extent.Conclusion These results open the possibility of taking TASA as an anti-inflammatory agent for H.py |
doi_str_mv | 10.3760/cma.j.issn.0366-6999.20140615 |
format | Article |
fullrecord | <record><control><sourceid>wanfang_jour_proqu</sourceid><recordid>TN_cdi_wanfang_journals_zhcmj201413016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>661683498</cqvip_id><wanfj_id>zhcmj201413016</wanfj_id><sourcerecordid>zhcmj201413016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-433220357f26c0ebe498fbad8127715a3571037f2716fbda829cbaee58a1c1cc3</originalsourceid><addsrcrecordid>eNo9kUtLxDAUhYMoOj7-ghRBcdOaR5OmCxeD-ALBhboOaSZxUtumJq0y_npT5rEKnPvdnMs5AFwimJGCwRvVyqzObAhdBgljKSvLMsMQ5ZAhugdmmOY4pSxH-2C2A47AcQg1hJjSgh2CI5yXnFLOZ-Bt3g02XerGKldJNWif9KvGeZtoY7QaEmeSwQ2ySWTzJRtnF2GSguuXzssoul6r0Uddh8R2yY_9cafgwMgm6LPNewI-Hu7f757Sl9fH57v5S6pywoc0JwRjSGhhMFNQVzoeZSq54AgXBaIyThAkcVogZqqF5LhUldSacokUUoqcgKv1v7-yM7L7FLUbfRcdxd9StfUUCiIQsQher8Heu-9Rh0G0NijdNLLTbgwCxcxYXhYcRfR2jSrvQvDaiN7bVvqVQFBMBYhYgKjFVICY8hVTvmJbQNw_31iNVasXu-1t4hG42BgsXff5bePZW4YxxDiJIPkHmvuQdA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1542649781</pqid></control><display><type>article</type><title>Anti-helicobacter pylori effect of total alkaloids of sophora alopecuroides in vivo</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Tian, Aiping ; Xu, Ting ; Liu, Kaiyun ; Zou, Quanming ; Yan, Xiang</creator><creatorcontrib>Tian, Aiping ; Xu, Ting ; Liu, Kaiyun ; Zou, Quanming ; Yan, Xiang</creatorcontrib><description>Background Helicobacterpylori (H.pylori) infection could lead to most gastroduodenal diseases and is even identified as a carcinogen of gastric cancer.Total alkaloids of sophora alopecuroides (TASA) is widely used in herbal remedies to treat various infectious diseases,including stomach-associated diseases.This study is aimed at evaluating the antimicrobial activity of TASA on H.pylori-infected BALB/c mice mouse gastritis.Methods Totally 120 BALB/c mice were orally inoculated with H.pylori Bacterial liquid to construct BALB/c mice H.pylori infection gastritis animal model,after the model was successfully created.We randomly assigned 100 infected mice into 10 treatment groups,the first group (normal saline); the second group (bismuth pectin); the third group (omeprazole); the fourth group (TASA 2 mg/d); the fifth group (TASA 4 mg/d); the sixth group (TASA 5 mg/d); the seventh group (TASA + bismuth pectin); the eighth group (TASA + omeprazole); the ninth group (bismuth pectin + clarithromycin + metronidazole);the tenth group (omeprazole + clarithromycin + metronidazole),5 other non-infected mice as negative control.Mice were orally inoculated twice a day and 7 days continuously.Then the mice were killed 4 weeks after treatment,we used realtime PCR to detect 16sDNA of H.pylori to test both the colonization and the clearance mice of bacteria of each treatment.We applied hematoxylin and eosin (HE) staining and immunostaining of mice gastric mucosa to observe the general inflammation and related factors interleukin 8 (IL-8),cyclooxygenase 2 (COX-2),and nuclear factor-kappa B (NF-KB) expression change after treatments.Results Firstly,we ensured that after 6-week intragastric administration,the bacteria colonization reached an exceed peak which is far higher than positive threshold (P <0.001); secondly,after treatments,it is revealed that TASA combined with omeprazole or bismuth pectin showed promising antimicrobial activity against H.pylori as well as conventional triple therapy (P <0.001); thirdly,HE staining showed that the inflammation on mice gastric mucosal membrane were also relieved obviously in TASA combined treatments and conventional triple therapy compared with normal saline treated mice,moreover,from immunohistochemistry results,H.pylori-induced IL-8,COX-2,and NF-KB were consistently suppressed in seventh,eighth,ninth,and tenth group to a certain extent.Conclusion These results open the possibility of taking TASA as an anti-inflammatory agent for H.pylori gastritis.</description><identifier>ISSN: 0366-6999</identifier><identifier>EISSN: 2542-5641</identifier><identifier>DOI: 10.3760/cma.j.issn.0366-6999.20140615</identifier><identifier>PMID: 24985588</identifier><language>eng</language><publisher>China: First Clinical Medical School of Lanzhou University, Lanzhou,Gansu 730000, China%Department of Clinical Microbiology, Third Military Medical University, Chongqing 400000, China%Department of Gerontology, First Hospital of Lanzhou University,Lanzhou, Gansu 730000, China</publisher><subject>Alkaloids - pharmacology ; Alkaloids - therapeutic use ; Animals ; Anti-Inflammatory Agents - pharmacology ; Anti-Inflammatory Agents - therapeutic use ; COX-2 ; Cyclooxygenase 2 - metabolism ; Female ; Helicobacter Infections - drug therapy ; Helicobacter pylori - drug effects ; Helicobacter pylori - metabolism ; Immunohistochemistry ; Interleukin-8 - metabolism ; Mice ; Mice, Inbred BALB C ; NF-kappa B - metabolism ; NF-κB ; Omeprazole - therapeutic use ; Real-Time Polymerase Chain Reaction ; Sophora - chemistry ; 奥美拉唑 ; 幽门螺旋杆菌 ; 幽门螺杆菌 ; 总生物碱 ; 感染性疾病 ; 苦豆子</subject><ispartof>Chinese medical journal, 2014, Vol.127 (13), p.2484-2491</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-433220357f26c0ebe498fbad8127715a3571037f2716fbda829cbaee58a1c1cc3</citedby><cites>FETCH-LOGICAL-c438t-433220357f26c0ebe498fbad8127715a3571037f2716fbda829cbaee58a1c1cc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85656X/85656X.jpg</thumbnail><link.rule.ids>314,776,780,860,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24985588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tian, Aiping</creatorcontrib><creatorcontrib>Xu, Ting</creatorcontrib><creatorcontrib>Liu, Kaiyun</creatorcontrib><creatorcontrib>Zou, Quanming</creatorcontrib><creatorcontrib>Yan, Xiang</creatorcontrib><title>Anti-helicobacter pylori effect of total alkaloids of sophora alopecuroides in vivo</title><title>Chinese medical journal</title><addtitle>Chinese Medical Journal</addtitle><description>Background Helicobacterpylori (H.pylori) infection could lead to most gastroduodenal diseases and is even identified as a carcinogen of gastric cancer.Total alkaloids of sophora alopecuroides (TASA) is widely used in herbal remedies to treat various infectious diseases,including stomach-associated diseases.This study is aimed at evaluating the antimicrobial activity of TASA on H.pylori-infected BALB/c mice mouse gastritis.Methods Totally 120 BALB/c mice were orally inoculated with H.pylori Bacterial liquid to construct BALB/c mice H.pylori infection gastritis animal model,after the model was successfully created.We randomly assigned 100 infected mice into 10 treatment groups,the first group (normal saline); the second group (bismuth pectin); the third group (omeprazole); the fourth group (TASA 2 mg/d); the fifth group (TASA 4 mg/d); the sixth group (TASA 5 mg/d); the seventh group (TASA + bismuth pectin); the eighth group (TASA + omeprazole); the ninth group (bismuth pectin + clarithromycin + metronidazole);the tenth group (omeprazole + clarithromycin + metronidazole),5 other non-infected mice as negative control.Mice were orally inoculated twice a day and 7 days continuously.Then the mice were killed 4 weeks after treatment,we used realtime PCR to detect 16sDNA of H.pylori to test both the colonization and the clearance mice of bacteria of each treatment.We applied hematoxylin and eosin (HE) staining and immunostaining of mice gastric mucosa to observe the general inflammation and related factors interleukin 8 (IL-8),cyclooxygenase 2 (COX-2),and nuclear factor-kappa B (NF-KB) expression change after treatments.Results Firstly,we ensured that after 6-week intragastric administration,the bacteria colonization reached an exceed peak which is far higher than positive threshold (P <0.001); secondly,after treatments,it is revealed that TASA combined with omeprazole or bismuth pectin showed promising antimicrobial activity against H.pylori as well as conventional triple therapy (P <0.001); thirdly,HE staining showed that the inflammation on mice gastric mucosal membrane were also relieved obviously in TASA combined treatments and conventional triple therapy compared with normal saline treated mice,moreover,from immunohistochemistry results,H.pylori-induced IL-8,COX-2,and NF-KB were consistently suppressed in seventh,eighth,ninth,and tenth group to a certain extent.Conclusion These results open the possibility of taking TASA as an anti-inflammatory agent for H.pylori gastritis.</description><subject>Alkaloids - pharmacology</subject><subject>Alkaloids - therapeutic use</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>COX-2</subject><subject>Cyclooxygenase 2 - metabolism</subject><subject>Female</subject><subject>Helicobacter Infections - drug therapy</subject><subject>Helicobacter pylori - drug effects</subject><subject>Helicobacter pylori - metabolism</subject><subject>Immunohistochemistry</subject><subject>Interleukin-8 - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>NF-kappa B - metabolism</subject><subject>NF-κB</subject><subject>Omeprazole - therapeutic use</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>Sophora - chemistry</subject><subject>奥美拉唑</subject><subject>幽门螺旋杆菌</subject><subject>幽门螺杆菌</subject><subject>总生物碱</subject><subject>感染性疾病</subject><subject>苦豆子</subject><issn>0366-6999</issn><issn>2542-5641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kUtLxDAUhYMoOj7-ghRBcdOaR5OmCxeD-ALBhboOaSZxUtumJq0y_npT5rEKnPvdnMs5AFwimJGCwRvVyqzObAhdBgljKSvLMsMQ5ZAhugdmmOY4pSxH-2C2A47AcQg1hJjSgh2CI5yXnFLOZ-Bt3g02XerGKldJNWif9KvGeZtoY7QaEmeSwQ2ySWTzJRtnF2GSguuXzssoul6r0Uddh8R2yY_9cafgwMgm6LPNewI-Hu7f757Sl9fH57v5S6pywoc0JwRjSGhhMFNQVzoeZSq54AgXBaIyThAkcVogZqqF5LhUldSacokUUoqcgKv1v7-yM7L7FLUbfRcdxd9StfUUCiIQsQher8Heu-9Rh0G0NijdNLLTbgwCxcxYXhYcRfR2jSrvQvDaiN7bVvqVQFBMBYhYgKjFVICY8hVTvmJbQNw_31iNVasXu-1t4hG42BgsXff5bePZW4YxxDiJIPkHmvuQdA</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Tian, Aiping</creator><creator>Xu, Ting</creator><creator>Liu, Kaiyun</creator><creator>Zou, Quanming</creator><creator>Yan, Xiang</creator><general>First Clinical Medical School of Lanzhou University, Lanzhou,Gansu 730000, China%Department of Clinical Microbiology, Third Military Medical University, Chongqing 400000, China%Department of Gerontology, First Hospital of Lanzhou University,Lanzhou, Gansu 730000, China</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>2014</creationdate><title>Anti-helicobacter pylori effect of total alkaloids of sophora alopecuroides in vivo</title><author>Tian, Aiping ; Xu, Ting ; Liu, Kaiyun ; Zou, Quanming ; Yan, Xiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-433220357f26c0ebe498fbad8127715a3571037f2716fbda829cbaee58a1c1cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Alkaloids - pharmacology</topic><topic>Alkaloids - therapeutic use</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>COX-2</topic><topic>Cyclooxygenase 2 - metabolism</topic><topic>Female</topic><topic>Helicobacter Infections - drug therapy</topic><topic>Helicobacter pylori - drug effects</topic><topic>Helicobacter pylori - metabolism</topic><topic>Immunohistochemistry</topic><topic>Interleukin-8 - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>NF-kappa B - metabolism</topic><topic>NF-κB</topic><topic>Omeprazole - therapeutic use</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>Sophora - chemistry</topic><topic>奥美拉唑</topic><topic>幽门螺旋杆菌</topic><topic>幽门螺杆菌</topic><topic>总生物碱</topic><topic>感染性疾病</topic><topic>苦豆子</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tian, Aiping</creatorcontrib><creatorcontrib>Xu, Ting</creatorcontrib><creatorcontrib>Liu, Kaiyun</creatorcontrib><creatorcontrib>Zou, Quanming</creatorcontrib><creatorcontrib>Yan, Xiang</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>Chinese medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tian, Aiping</au><au>Xu, Ting</au><au>Liu, Kaiyun</au><au>Zou, Quanming</au><au>Yan, Xiang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-helicobacter pylori effect of total alkaloids of sophora alopecuroides in vivo</atitle><jtitle>Chinese medical journal</jtitle><addtitle>Chinese Medical Journal</addtitle><date>2014</date><risdate>2014</risdate><volume>127</volume><issue>13</issue><spage>2484</spage><epage>2491</epage><pages>2484-2491</pages><issn>0366-6999</issn><eissn>2542-5641</eissn><abstract>Background Helicobacterpylori (H.pylori) infection could lead to most gastroduodenal diseases and is even identified as a carcinogen of gastric cancer.Total alkaloids of sophora alopecuroides (TASA) is widely used in herbal remedies to treat various infectious diseases,including stomach-associated diseases.This study is aimed at evaluating the antimicrobial activity of TASA on H.pylori-infected BALB/c mice mouse gastritis.Methods Totally 120 BALB/c mice were orally inoculated with H.pylori Bacterial liquid to construct BALB/c mice H.pylori infection gastritis animal model,after the model was successfully created.We randomly assigned 100 infected mice into 10 treatment groups,the first group (normal saline); the second group (bismuth pectin); the third group (omeprazole); the fourth group (TASA 2 mg/d); the fifth group (TASA 4 mg/d); the sixth group (TASA 5 mg/d); the seventh group (TASA + bismuth pectin); the eighth group (TASA + omeprazole); the ninth group (bismuth pectin + clarithromycin + metronidazole);the tenth group (omeprazole + clarithromycin + metronidazole),5 other non-infected mice as negative control.Mice were orally inoculated twice a day and 7 days continuously.Then the mice were killed 4 weeks after treatment,we used realtime PCR to detect 16sDNA of H.pylori to test both the colonization and the clearance mice of bacteria of each treatment.We applied hematoxylin and eosin (HE) staining and immunostaining of mice gastric mucosa to observe the general inflammation and related factors interleukin 8 (IL-8),cyclooxygenase 2 (COX-2),and nuclear factor-kappa B (NF-KB) expression change after treatments.Results Firstly,we ensured that after 6-week intragastric administration,the bacteria colonization reached an exceed peak which is far higher than positive threshold (P <0.001); secondly,after treatments,it is revealed that TASA combined with omeprazole or bismuth pectin showed promising antimicrobial activity against H.pylori as well as conventional triple therapy (P <0.001); thirdly,HE staining showed that the inflammation on mice gastric mucosal membrane were also relieved obviously in TASA combined treatments and conventional triple therapy compared with normal saline treated mice,moreover,from immunohistochemistry results,H.pylori-induced IL-8,COX-2,and NF-KB were consistently suppressed in seventh,eighth,ninth,and tenth group to a certain extent.Conclusion These results open the possibility of taking TASA as an anti-inflammatory agent for H.pylori gastritis.</abstract><cop>China</cop><pub>First Clinical Medical School of Lanzhou University, Lanzhou,Gansu 730000, China%Department of Clinical Microbiology, Third Military Medical University, Chongqing 400000, China%Department of Gerontology, First Hospital of Lanzhou University,Lanzhou, Gansu 730000, China</pub><pmid>24985588</pmid><doi>10.3760/cma.j.issn.0366-6999.20140615</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0366-6999 |
ispartof | Chinese medical journal, 2014, Vol.127 (13), p.2484-2491 |
issn | 0366-6999 2542-5641 |
language | eng |
recordid | cdi_wanfang_journals_zhcmj201413016 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Alkaloids - pharmacology Alkaloids - therapeutic use Animals Anti-Inflammatory Agents - pharmacology Anti-Inflammatory Agents - therapeutic use COX-2 Cyclooxygenase 2 - metabolism Female Helicobacter Infections - drug therapy Helicobacter pylori - drug effects Helicobacter pylori - metabolism Immunohistochemistry Interleukin-8 - metabolism Mice Mice, Inbred BALB C NF-kappa B - metabolism NF-κB Omeprazole - therapeutic use Real-Time Polymerase Chain Reaction Sophora - chemistry 奥美拉唑 幽门螺旋杆菌 幽门螺杆菌 总生物碱 感染性疾病 苦豆子 |
title | Anti-helicobacter pylori effect of total alkaloids of sophora alopecuroides in vivo |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T01%3A27%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-helicobacter%20pylori%20effect%20of%20total%20alkaloids%20of%20sophora%20alopecuroides%20in%20vivo&rft.jtitle=Chinese%20medical%20journal&rft.au=Tian,%20Aiping&rft.date=2014&rft.volume=127&rft.issue=13&rft.spage=2484&rft.epage=2491&rft.pages=2484-2491&rft.issn=0366-6999&rft.eissn=2542-5641&rft_id=info:doi/10.3760/cma.j.issn.0366-6999.20140615&rft_dat=%3Cwanfang_jour_proqu%3Ezhcmj201413016%3C/wanfang_jour_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1542649781&rft_id=info:pmid/24985588&rft_cqvip_id=661683498&rft_wanfj_id=zhcmj201413016&rfr_iscdi=true |